Clinical trials
Humans clinical trials
Below are recruiting humans clinical trials, each written for real people, not researchers. We’re tracking 1,228 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07746141RecruitingPhase 1
Study of BG-85738 for advanced solid tumors with RAS mutations
This trial is testing a new drug called BG-85738, which may target cancer cells that have a specific change (mutation) in the RAS gene. The goal is to see if it is safe and works against advanced or spreading solid tumors.
South Brisbane, QueenslandAges 18 years+ - NCT06319079Recruiting
Milk drink for nursing moms and breast milk quality
This study tests if a special milk product for breastfeeding mothers changes the nutrients in their breast milk. It may help you understand how your diet affects your baby's milk.
La Plata, Buenos AiresAges 18 years+ - NCT06463392Recruiting
Deep learning tool to diagnose post-radiation nasopharyngeal changes
This trial tests a new computer-based tool (deep learning) to help diagnose a condition called sbORN (suspected benign or recurrent nasopharyngeal carcinoma) after radiation therapy. It aims to see if the tool can accurately tell if a suspicious spot is a recurrence or something harmless.
Guangzhou, GuangdongAges 18 years+ - NCT07735221Recruiting
Peanuts for stress and heart health
This trial tests whether eating peanuts every day can reduce stress, improve immune function, and lower inflammation in people who feel stressed. If you are stressed and generally healthy, you may qualify.
Davis, CaliforniaAges 18–65 - NCT07738978Recruiting
Movement and health study for paralysis
This study is looking at ways to improve movement and health for people with paralysis from conditions like spinal cord injury, stroke, traumatic brain injury, or multiple sclerosis. It involves exercises and may include electrical stimulation to help your leg and trunk muscles work better.
Cleveland, OhioAges 18 years+ - NCT07737275Recruiting
Portable x-ray screening for tuberculosis in recent migrants
This trial uses a portable x-ray machine to quickly check for tuberculosis (TB) in people who recently moved to the US. It aims to make TB screening easier and faster for migrants.
New York, New YorkAges 18 years+ - NCT07735104RecruitingPhase 1/Phase 2
Study of a new drug for cancer-related weight loss
This study tests a new medicine (QLS2319) to see if it’s safe and can help people with cancer-related weight loss and muscle loss (cachexia). It’s for people whose daily activities aren’t severely limited by their cancer.
Hefei, AnhuiAges 18–55 - NCT06626113Recruiting
Nerve activity and obesity study
This trial looks at how the nerves that control blood pressure work in people with obesity and insulin resistance. It may help explain why some people develop high blood pressure and others don't.
Kansas City, KansasAges 18–79 - NCT07726147RecruitingPhase 1
Testing a new allergy shot for Japanese cedar pollen
This trial tests a new allergy shot (ITI-9001) for people with Japanese cedar pollen allergy. It aims to see if the shot is safe and can reduce allergy symptoms. The study is for people who have not tried immunotherapy before.
Tokyo, Shinjuku-kuAges 18–65 - NCT07724405RecruitingPhase 2
G-CSF for Unexplained Recurrent Miscarriage During IVF
This study tests whether G-CSF (a medicine that helps the immune system) given during IVF can reduce miscarriages in women who have had repeated pregnancy losses with no clear reason.
Abu DhabiAges 18–44 - NCT06630923RecruitingPhase 3
Preventing kidney worsening with IV albumin in heart failure
This trial tests if giving a medicine called albumin through a vein can help prevent kidney function from getting worse in people hospitalized with worsening heart failure and liver problems. It may be an option if other treatments haven't worked.
Alexandroupoli, EvrosAges 18–95 - NCT05942625RecruitingPhase 1
Study of an experimental drug in healthy adults
This Phase 1 trial tests how safe and tolerable an experimental medicine (HS-10390) is in healthy adults, and how the body processes it. It is not for people with an illness, but for healthy volunteers to help researchers understand the drug before future studies.
Nanjing, JiangsuAges 18–45 - NCT06633120Recruiting
Growing eggs in the lab for women with PCOS
This study tests a way to mature eggs outside the body for women with PCOS or high ovarian reserve. It might help avoid side effects from fertility medications.
Lone Tree, ColoradoAges Up to 38 years - NCT07715201Recruiting
Amino acid drink for strength and recovery in active men
This study tests whether a special amino acid supplement helps trained men get stronger, perform better, and recover faster from workouts. You'll take the supplement daily and follow a 10-week supervised training program.
Toronto, OntarioAges 18–45 - NCT07720414Recruiting
GLP-1 Meds and Breastfeeding Study
This study tests whether a type of diabetes/weight loss medication (GLP-1 RA, given as a shot) affects milk production in breastfeeding mothers. It may help women who need this medicine while nursing.
Aurora, ColoradoAges Any age - NCT07721649Recruiting
Flu shot during hospital stay for heart patients
This study checks if giving a flu shot to heart patients while they are in the hospital helps prevent heart problems later. It tests whether the flu shot can reduce the risk of further heart events.
CologneAges 18 years+ - NCT05278715RecruitingPhase 2
New treatment plan for optic pathway glioma in children
This Phase 2 trial tests a modified chemotherapy treatment plan for children and young people with optic pathway glioma, aiming to shrink tumor and improve eye/brain symptoms. You may be able to join if your diagnosis is confirmed and your body can safely handle treatment.
BeijingAges 3 months–21 years - NCT06211868Recruiting
Early heart disease risk study for adults 40-70
This study looks at whether changing your immune system, fats, and metabolism can lower your risk of early heart disease. It is for people with an intermediate to high risk score but who have not yet had a heart attack or stroke.
SingaporeAges 40–70 - NCT07706686RecruitingPhase 1
Dengue challenge study in people with prior infection
This study tests how the body responds to a mild, lab-made dengue virus in people who have had dengue before. It looks at how the immune system reacts to a second infection, which may help improve future vaccines and treatments.
Bethesda, MarylandAges 18–50 - NCT07708116RecruitingPhase 1
First human trial of CTX-187 for healthy people and those with chronic infection
This trial tests a new drug called CTX-187 in two groups: healthy volunteers (Parts A and B) and people with chronic lung infection from bronchiectasis (Part C). It helps find the right dose and checks safety.
GroningenAges 18–65 - NCT07712939RecruitingPhase 1
Study of CND319 for rheumatic diseases
This study tests a new drug called CND319 in healthy volunteers and people with rheumatoid arthritis or Sjögren's disease. The goal is to see if it is safe and how the body responds to it.
Melbourne, VictoriaAges 18–65 - NCT07712445Recruiting
Testing a clot-busting drug coated with platelet membranes
This study tests a new way to deliver a clot-dissolving drug called tenecteplase. The drug is coated with platelet membranes to target blood clots in arteries. It may offer a safer, more effective treatment for heart attack patients and is also enrolling healthy volunteers for comparison.
Nanjing, JiangsuAges 18–75 - NCT07707778Enrolling by invitationPhase 4
Tirzepatide for Weight and Aging in People with HIV
This trial tests whether a weight-loss medicine called tirzepatide can slow biological aging and improve metabolism in people with HIV who are already on effective treatment. It may help you reduce weight and possibly reverse some signs of aging.
TaipeiAges 18 years+ - NCT07707531RecruitingEarly Phase 1
Trial of radioactive drug for gastric and pancreatic cancer
This study tests a radioactive drug that targets a protein called Claudin 18.2 found on some stomach and pancreatic cancer cells. Researchers will track where the drug goes in your body and how it exits, to see if it's a safe and effective way to deliver radiation directly to tumors.
ShanghaiAges 18 years+
Hear when a new Humans trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for humans?
- Yes. Clin2 currently lists 1,228 recruiting humans studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a humans trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a humans trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.